Results of bivariate analysis to determine the significant relative odds of having anti-RVFV seropositivity according to demographic data, clinical signs, symptoms, and exposure factors.

† As determined by bivariate Χ2 testing
*Poor visual acuity defined functionally at >6/9 meters using a Snellen eye chart
^ “Recent” defined as symptoms reported in the last 30 days
< “History of” defined as symptom reported at any time
** N = number of participants with data collected in survey
Results of bivariate analysis to determine the significant relative odds of having anti-RVFV seropositivity according to demographic data, clinical signs, symptoms, and exposure factors.